ARTICLE | Finance
Biotech investor, banker and analyst personnel changes
February 13, 2012 8:00 AM UTC
James Tyree is retiring as president of Abbott Biotech Ventures Inc., a venture capital arm of Abbott Laboratories (NYSE:ABT).
Gregory Grunberg joined Longitude Capitalas a managing director. He was a principal at Rho Ventures. Longitude has $325 million under management...